Jun 01, 2010 - Covidien Announces Portfolio Management Activities - Definitive Agreement to Sell Sleep Therapy Product Line - Completion of Sale of U.S. Radiopharmacies - Covidien (NYSE: COV), a leading global provider of healthcare products, announced a definitive agreement to sell its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a privately held company located in Luxembourg.PH Invest will acquire the CPAP and Bi-level products, including the Nancy, France manufacturing facility, as well as related commercial operations in Europe. Several products, which are sold under the GoodKnight(TM) and Sandman(TM) brands, are included in this agreement. The agreement excludes the sleep interface products sold and marketed under the brand names Adam(TM), Breeze(TM) and Dreamfit(TM), which will continue to be sold by Covidien. Financial terms of this transaction were not disclosed... Covidien's Press Release -
